Bad Weed

A Case of Prolonged Psychosis Secondary to Synthetic Cannabinoids

Authors

  • Karen E. Moeller, Pharm.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS; University of Kansas School of Pharmacy, Department of Pharmacy Practice, Lawrence, KS
  • Nischal Sager, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Todd Mekles, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Amad Din, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Ann Genovese, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Sadiq Naveed, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS
  • Andrew Demo, M.D. University of Kansas School of Medicine, Department of Psychiatry and Behavior Science, Kansas City, KS

DOI:

https://doi.org/10.17161/kjm.v9i2.8607

Keywords:

cannabis, cannabinoids, psychotic disorders

Downloads

Published

2019-01-08

How to Cite

Moeller, K. E., Sager, N., Mekles, T., Din, A., Genovese, A., Naveed, S., & Demo, A. (2019). Bad Weed: A Case of Prolonged Psychosis Secondary to Synthetic Cannabinoids. Kansas Journal of Medicine, 9(2), 43–44. https://doi.org/10.17161/kjm.v9i2.8607

Issue

Section

Case Reports